Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 3082 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2508    
    Printed117    
    Emailed11    
    PDF Downloaded272    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 
ORIGINAL ARTICLE
Year : 2009  |  Volume : 51  |  Issue : 3  |  Page : 202-205

Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients


1 Department of Psychiatry, Command Hospital, Alipore, Kolkata, West Bengal, India
2 Military Hospital, Jhansi, UP, India

Correspondence Address:
Pradyot Sarkar
Department of Psychiatry, Command Hospital (EC), Alipore, Kolkata - 700 027
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-5545.55089

Rights and Permissions

Background: Neuroleptic malignant syndrome (NMS) is the most serious and potentially fatal adverse effect of neuroleptic medications. Although it occurs most frequently with conventional antipsychotic medicines, it may occur with newer antipsychotic medicines also. So far, there is no study available about the prevalence of this condition in the Indian population. Aim: To find the prevalence of NMS in the Indian population . Materials and Methods: A total of 672 consecutive male patients who were hospitalized with psychotic breakdowns and treated with neuroleptics were screened for evidence of the development of NMS, clinically, and supported by laboratory investigations. Results: Three patients, all suffering from manic episode, developed NMS within few days of initiation of neuroleptic medicines. Haloperidol injection was given in all three cases . Conclusion: The prevalence of NMS was 0.45%. All were young males, suffering from manic episode with psychotic symptoms and managed with oral and parentral neuroleptic medicines.



[FULL TEXT] [PDF]*

        

Print this article         Email this article